Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
78.59
+0.47 (+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrazeneca Plc ADR
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
55
56
Next >
We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit
June 10, 2022
The conversation around obesity is changing. Two diabetes drug makers are at the forefront.
Via
Investor's Business Daily
5 Cathie Wood Stocks to Buy in June
June 09, 2022
These are the five best Cathie Wood stocks to buy in June. EXAS, IONS, KTOS, TRMB, and PATH can make excellent investments.
Via
InvestorPlace
COVID-19 Vaccine Patent Waiver Expected Soon, Says WTO Head: Reuters
June 08, 2022
Via
Benzinga
Breakthroughs In Treating Killer Diseases Could Lengthen Life
June 07, 2022
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
May 23, 2022
Via
Benzinga
AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s)
May 17, 2022
Via
Benzinga
AstraZeneca's Combination Inhaler Shines In Phase 3 Asthma Trial
May 16, 2022
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 6
June 06, 2022
Reuters
Via
Benzinga
AstraZeneca-Daiichi Breast Cancer Drug Cuts Disease Progression Or Death Risk By Almost 50%
June 06, 2022
Via
Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.
Via
Benzinga
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Reduced the Risk of Disease Progression or Death by 50% vs. Chemotherapy in Patients with HER2-Low Metastatic Breast Cancer with HR-Positive and HR-Negative Disease
June 05, 2022
From
AstraZeneca
Via
Business Wire
CALQUENCE Plus Obinutuzumab Demonstrated Sustained Survival Benefit in 1st-line Chronic Lymphocytic Leukemia with 90% of Patients Surviving Five Years in ELEVATE-TN Trial
June 04, 2022
From
AstraZeneca
Via
Business Wire
Abbott Stock Looks To Emerge From Bear Market Stronger
June 01, 2022
Abbott stock also has a 92 Composite Rating, placing it in the top 8% for a group of five key ratings, including EPS.
Via
Investor's Business Daily
First Patients Dosed in IRIS Phase III Trial Evaluating Anifrolumab in Lupus Nephritis
May 27, 2022
From
AstraZeneca
Via
Business Wire
European Regulator Approves AstraZeneca's COVID-19 shot As Booster
May 23, 2022
Via
Benzinga
AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
May 23, 2022
From
AstraZeneca
Via
Business Wire
Oncocyte Reports That Its First-Of-Its-Kind DetermaCNI Blood Test That Tracks Cancer Treatment Progress Could Hit Market By 2023
May 19, 2022
Image by Nguyễn Hiệp on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
5 Stocks to Buy for the Coming Recession
May 18, 2022
Each of these stocks to buy are low-beta stocks with attractive dividend yields to help endure a recession.
Via
InvestorPlace
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
May 16, 2022
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing.
Via
Talk Markets
PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As-Needed Rescue Medicine, Significantly Reduced the Risk of a Severe Exacerbation Compared to Albuterol by 27% in Patients With Asthma
May 15, 2022
From
AstraZeneca
Via
Business Wire
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
May 13, 2022
Via
Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
May 13, 2022
The Biden administration says it currently has no plans to share COVID-19 vaccines with North Korea, Reuters reported citing White House press secretary Jen Psaki. However, it supported providing aid...
Via
Benzinga
Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco
May 11, 2022
Via
Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
May 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV
May 11, 2022
Sanofi SA (NASDAQ: SNY) and AstraZeneca plc (NASDAQ: AZN) have announced results from a prespecified pooled analysis of nirsevimab in respiratory syncytial virus (RSV).
Via
Benzinga
PR Agency Tells Blue-Chip Clients Like AT&T, Coca-Cola, Netflix And More To Avoid Media Inquiries On Abortion Debate
May 06, 2022
A prominent public relations agency is warning its publicly traded clients to avoid making any comments on the Roe v.
Via
Benzinga
FDA Approval For AstraZeneca - Daiichi's Enhertu Expands To Earlier Use In Metastatic Breast Cancer
May 05, 2022
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
US Study Shows Omicron As Severe As Previous COVID Variants: Reuters
May 05, 2022
Via
Benzinga
FARXIGA met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure in patients with preserved ejection fraction
May 05, 2022
From
AstraZeneca
Via
Business Wire
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.